Profiel
Douglas Maffei is currently the Vice President-Investor Relations at Seagen Inc. He previously worked as a Senior Director-Investor Relations at Gilead Sciences, Inc.
Actieve functies van Douglas Maffei
| Bedrijven | Functie | Begin |
|---|---|---|
| SEAGEN INC. | Investor Relations Contact | - |
Eerdere bekende functies van Douglas Maffei
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
